Baxter to Proceed with Recall of Remaining Heparin Sodium Vial Products
No commentsFOR IMMEDIATE RELEASE — DEERFIELD, Ill., February 28, 2008 – Baxter International Inc. announced today that the company is proceeding with the voluntary recall of all remaining lots and doses of its heparin sodium injection multi-dose, single-dose vials and HEP-LOCK heparin flush products. The company initially recalled nine lots of heparin sodium injection multi-dose vials on January 17, 2008 as a precautionary measure due to a higher than usual number of reports of adverse patient reactions involving the product and suspended production earlier this month.
Friday, August 29th, 2008 at 12:00 am and is filed under alerts, cheaps meds, drugs and pharmaceuticals, health reform, medical doctors. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
Leave a reply